Hui Luo
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Inflammatory Biomarkers in Disease Prognosis
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 119
- Colorectal Cancer Treatments and Studies 34
- Cancer Immunotherapy and Biomarkers 30
- Pancreatic and Hepatic Oncology Research 18
- Co-authors
- Rui‐Hua Xu (106 shared papers)Miao‐Zhen Qiu (58 shared papers)De‐Shen Wang (36 shared papers)Yuhong Li (52 shared papers)Dong-sheng Zhang (28 shared papers)Zhao-Lei Zeng (24 shared papers)Chao Ren (32 shared papers)Xueqiong Zhu (12 shared papers)
- Journals
- Journal of Clinical Oncology (12 papers)PLoS ONE (12 papers)Tumor Biology (11 papers)Journal of Translational Medicine (7 papers)Frontiers in Immunology (7 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Hui Luo
269 papers receiving 6.5k citations
Hui Luo's Hit Papers
Peers
Comparison fields: 5 of 158
- Cancer Research 1.7k
- Oncology 2.7k
- Hepatology 340
- Pulmonary and Respiratory Medicine 1.3k
- Molecular Biology 2.4k
Countries citing papers authored by Hui Luo
This map shows the geographic impact of Hui Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Luo more than expected).
Fields of papers citing papers by Hui Luo
This network shows the impact of papers produced by Hui Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Luo. The network helps show where Hui Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Hui Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 291 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Molecular mechanisms of cisplatin resistance in cervical cancer Hit paper breakdown → | 2016 | 295 |
| 2 | 2016 | 216 | |
| 3 | Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA Hit paper breakdown → | 2021 | 210 |
| 4 | 2012 | 194 | |
| 5 | Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response Hit paper breakdown → | 2022 | 167 |
| 6 | 2015 | 140 | |
| 7 | 2013 | 120 | |
| 8 | 2014 | 109 | |
| 9 | 2021 | 108 | |
| 10 | 2011 | 105 | |
| 11 | 2021 | 104 | |
| 12 | 2007 | 104 | |
| 13 | 2019 | 100 | |
| 14 | 2011 | 97 | |
| 15 | 2012 | 94 | |
| 16 | 2016 | 93 | |
| 17 | 2019 | 89 | |
| 18 | 2005 | 82 | |
| 19 | 2018 | 79 | |
| 20 | 2018 | 75 |
About Hui Luo
Hui Luo is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Surgery and Cancer Research, having authored 291 papers that have together received 6.6k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (44 papers), Colorectal Cancer Treatments and Studies (34 papers), Cancer Immunotherapy and Biomarkers (30 papers), Pancreatic and Hepatic Oncology Research (18 papers), Cancer Genomics and Diagnostics (16 papers), Gastrointestinal Tumor Research and Treatment (15 papers), Cancer-related molecular mechanisms research (15 papers) and Immune Cell Function and Interaction (15 papers). The work is most often cited by research in Cancer Research (1.7k citations), Oncology (2.7k citations), Hepatology (340 citations), Pulmonary and Respiratory Medicine (1.3k citations) and Molecular Biology (2.4k citations). Hui Luo has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Rui‐Hua Xu, Miao‐Zhen Qiu, De‐Shen Wang, Yuhong Li, Dong-sheng Zhang, Zhao-Lei Zeng, Chao Ren, Xueqiong Zhu, Feng Wang and Feng-Hua Wang. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE, Tumor Biology, Journal of Translational Medicine and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.